tiprankstipranks
BioCryst price target raised to $8 from $7 at Barclays
The Fly

BioCryst price target raised to $8 from $7 at Barclays

Barclays raised the firm’s price target on BioCryst (BCRX) to $8 from $7 and keeps an Equal Weight rating on the shares post the Q3 report. Orladeyo’s Q3 revenue was a modest beat and the company’s 2024 revenue guidance was narrowed to the upper end of tee range, the analyst tells investors in a research note.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App